John Ransom analyst RAYMOND JAMES

Currently out of the existing stock ratings of John Ransom, 216 are a BUY (91.53%), 1 are a SELL (0.42%), 19 are a HOLD (8.05%).

John Ransom

Work Performance Price Targets & Ratings Chart

Analyst John Ransom, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 69.2% that have a potential upside of 42.67% achieved within 271 days.

John Ransom’s has documented 428 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Consumer Cyclical, Financial Services sectors.

Most recent stock forecast was given on HCA, HCA Holdings at 22-Nov-2024.

Wall Street Analyst John Ransom

Analyst best performing recommendations are on CANO (CANO HEALTH).
The best stock recommendation documented was for DVA (DAVITA HEALTHCARE PARTNERS) at 11/28/2017. The price target of $65 was fulfilled within 8 days with a profit of $6.52 (11.15%) receiving and performance score of 13.94.

Average potential price target upside

ACHC Acadia Healthcare Company ADUS Addus HomeCare ALHC Alignment Healthcare LLC AMED Amedisys AVAH Aveanna Healthcare Holdings CI Cigna Corp CVET Covetrus CVS CVS Health Corp DVA DaVita HealthCare Partners EHC Encompass Health Corp HCA HCA Holdings HSKA Heska OSH Oak Street Health PHR Phreesia RDNT RadNet THC Tenet Healthcare UNH UnitedHealth Group orporated AGTI Agiliti HCAT Health Catalyst AIRS Airsculpt Technologies PINC Premier SCI Service International CANO Cano Health ACCD Accolade  CHNG Change Healthcare TRUP Trupanion

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$75

$37.1 (97.89%)

$75

10 days ago
(12-Dec-2024)

9/10 (90%)

$33.08 (78.91%)

95

Hold

$52

$14.1 (37.20%)

$90

12 days ago
(10-Dec-2024)

2/12 (16.67%)

$12.13 (30.42%)

133

Buy

$43

$5.1 (13.46%)

$76

1 months ago
(22-Nov-2024)

2/11 (18.18%)

$4.55 (11.83%)

304

Buy

$64

$26.1 (68.87%)

$94

1 months 4 days ago
(18-Nov-2024)

0/7 (0%)

$27.48 (75.25%)

Buy

$91

$53.1 (140.11%)

$101

7 months 5 days ago
(17-May-2024)

1/4 (25%)

$24.65 (37.15%)

70

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is John Ransom is most bullish on?

Potential upside of $65.54 has been obtained for THC (TENET HEALTHCARE)

Which stock is John Ransom is most reserved on?

Potential downside of -$0 has been obtained for HCA (HCA HOLDINGS)

What Year was the first public recommendation made by John Ransom?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?